Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2024
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial
David J Einstein, Meredith M Regan, Julia S Stevens, et al.
Journal of Oncology Practice
|
June 1, 2017
Improving End-of-Life Care: Palliative Care Embedded in an Oncology Clinic Specializing in Targeted and Immune-Based Therapies
David J Einstein, Susan DeSanto-Madeya, Matthew Gregas, et al.
JCO Precision Oncology
|
January 20, 2022
Assessment of Molecular Remission in Oligometastatic Esophageal Cancer With a Personalized Circulating Tumor DNA Assay
David J Einstein, Nathan Liang, Meenakshi Malhotra, et al.
Molecular Cancer Therapeutics
|
October 3, 2025
Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancer
Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia, et al.
The Urologic Clinics of North America
|
October 3, 2020
The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer
Marijo Bilusic, David J Einstein, Fatima H Karzai, et al.
Urology
|
February 22, 2019
Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer
David J Einstein, Dattatraya Patil, Jonathan Chipman, et al.
Molecular Cancer Therapeutics
|
June 19, 2024
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer
Mannan Nouri, Andreas Varkaris, Maya Ridinger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 18, 2026
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic Therapy
David J Einstein, Ronald C Chen, Karen E Hoffman, et al.
JCO Precision Oncology
|
September 27, 2021
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
David J Einstein, Seiji Arai, Carla Calagua, et al.
Cancer Letters
|
September 16, 2018
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
Joshua W Russo, Xiaming Liu, Huihui Ye, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2024
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial
David J Einstein, Meredith M Regan, Julia S Stevens, et al.
Journal of Oncology Practice
|
June 1, 2017
Improving End-of-Life Care: Palliative Care Embedded in an Oncology Clinic Specializing in Targeted and Immune-Based Therapies
David J Einstein, Susan DeSanto-Madeya, Matthew Gregas, et al.
JCO Precision Oncology
|
January 20, 2022
Assessment of Molecular Remission in Oligometastatic Esophageal Cancer With a Personalized Circulating Tumor DNA Assay
David J Einstein, Nathan Liang, Meenakshi Malhotra, et al.
Molecular Cancer Therapeutics
|
October 3, 2025
Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancer
Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia, et al.
The Urologic Clinics of North America
|
October 3, 2020
The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer
Marijo Bilusic, David J Einstein, Fatima H Karzai, et al.
Urology
|
February 22, 2019
Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer
David J Einstein, Dattatraya Patil, Jonathan Chipman, et al.
Molecular Cancer Therapeutics
|
June 19, 2024
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer
Mannan Nouri, Andreas Varkaris, Maya Ridinger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 18, 2026
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic Therapy
David J Einstein, Ronald C Chen, Karen E Hoffman, et al.
JCO Precision Oncology
|
September 27, 2021
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
David J Einstein, Seiji Arai, Carla Calagua, et al.
Cancer Letters
|
September 16, 2018
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
Joshua W Russo, Xiaming Liu, Huihui Ye, et al.
Page
of 6